✦ LIBER ✦

BRCA1 and BRCA2 hereditary breast carcinoma phenotypes

✍ Scribed by Joseph N. Marcus; David L. Page; Patrice Watson; Steven A. Narod; Gilbert M. Lenoir; Henry T. Lynch

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 652 KB
Volume: 80
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19970801)80:3+<543::aid-cncr4>3.0.co;2-a

No coin nor oath required. For personal study only.

✦ Synopsis

RESULTS.

BRCA1 is an estrogen-inducable cell cycle-associated protein with antiproliferation and tumor suppressor function. Less is known about BRCA2 protein 1 Department of Pathology, St. Luke's Hospital, but it has some similarities to BRCA1. Release of cells from BRCA1 control through Chesterfield, Missouri. germline mutations gives rise to genetically evolved breast carcinomas with a highly distinctive and correspondent proliferator phenotype featuring aneuploidy, 2 Department of Pathology, Vanderbilt

📜 SIMILAR VOLUMES

High risk of contralateral breast carcin

High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma

✍ Katarina Shahedi; Monica Emanuelsson; Fredrik Wiklund; Henrik Gronberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

Clinicopathologic analysis of BRCA1- or

Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women

✍ Shinzaburo Noguchi; Tsutomu Kasugai; Yoshio Miki; Takashi Fukutomi; Mitsuru Emi; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## BACKGROUND. The purpose of this investigation was to elucidate the clinicopathologic characteristics of BRCA1-and BRCA2-associated hereditary breast carcinomas (HBCs) in Japanese women.

Pathologic characteristics of breast par

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

✍ Camilo Adem; Carol Reynolds; Cheryl L. Soderberg; Jeffrey M. Slezak; Shannon K. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## BACKGROUND BRCA1 and BRCA2 alterations are associated with an increased risk of developing breast carcinoma. The authors hypothesized that the progression of breast neoplasia may differ between patients with hereditary disease and patients with nonhereditary disease and that this di

Breast carcinoma in carriers of BRCA1 or

Breast carcinoma in carriers of BRCA1 or BRCA2 mutations : Implications of proposed distinct histologic phenotypes

✍ Kelly-Anne Phillips 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Hereditary breast and ovarian cancer in

Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2

✍ Alexander Liede; Steven A. Narod 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Ethnic differences in cancer incidence and mortality result from differences in genetic and epidemiologic risk factors. Mutations in BRCA1 and BRCA2 account for a small proportion of all breast cancer cases, but for a much higher proportion of cases with a strong family history of breast or ovarian

Steroid receptors in hereditary breast c

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

✍ Niklas Loman; Oskar Johannsson; Pär-Ola Bendahl; Åke Borg; Mårten Fernö; Håkan O 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

## BACKGROUND. The expression of steroid receptors is a common feature of both male and female breast carcinomas and is also one of the most important prognostic factors for patients with this disease. Steroid receptor levels in BRCA1related breast carcinoma have reportedly been low. Little data o